Associated Papers
DDX5 is a multifunctional co-activator of steroid hormone receptors.
Wagner M et al.
Molecular and Cellular Endocrinology, 2012
Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor.
Malloy PJ et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2011
Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ et al.
Plos One, 2011
Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB et al.
Molecular Carcinogenesis, 2010
Alternative promoters and renal cell-specific regulation of the mouse type IIa sodium-dependent phosphate cotransporter gene.
Yamamoto H et al.
Biochimica Et Biophysica Acta, 2005
Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2005
Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity.
Jiménez-Lara AM et al.
The Journal of Biological Chemistry, 1999
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system.
Rachez C et al.
Genes & Development, 1998
Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor.
Nakajima S et al.
Molecular and Cellular Endocrinology, 1998
Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
Masuyama H et al.
Molecular Endocrinology (baltimore, Md.), 1997
Select a paper to view details